Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON-TIMI 38 Substudy-Reference-Cited by-同舟云学术

Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON-TIMI 38 Substudy

Published:2012-06 Issue:6 Volume:52 Page:789-797
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Riesmeyer Jeffrey S.,Salazar Daniel E.,Weerakkody Govinda J.,Ni Lan,Wrishko Rebecca E.,Ernest C. Steven,Luo Junxiang,Li Ying G.,Small David S.,Rohatagi Shashank,Macias William L.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270011406280/fullpdf

Reference27 articles.

1. Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity;Niitsu;Semin Thromb Hemost,2005

2. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis;Savi;Semin Thromb Hemost,2005

3. Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel;Geiger;Arterioscler Thromb Vasc Biol,1999

4. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

5. Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease;Wallentin;Eur Heart J,2008

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation;Clinical Pharmacokinetics;2024-01-20

2. Prescription patterns of P2Y12 inhibitors following revascularization in the United States: 2013–2018;Clinical and Translational Science;2023-08-03

3. Precision antiplatelet therapy;Research and Practice in Thrombosis and Haemostasis;2023-03

4. Acute Coronary Syndrome in the Older Adult Populations;Contemporary Cardiology;2023

5. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28